Group 1 - The core viewpoint of the announcement is that the Supervisory Board of Suzhou Helin Micro-Nano Technology Co., Ltd. approved the use of self-owned funds to pay for the required funds of the fundraising project and to replace them with the raised funds [1][2] - The meeting was held on June 13, 2025, with all necessary procedures followed, and the resolution was deemed legal and effective [1] - The voting results showed unanimous support with 3 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The Supervisory Board confirmed that the use of self-owned funds does not affect the normal implementation of the fundraising project and does not change the purpose of the raised funds [1]

证券代码：688661 证券简称：和林微纳 编号：2025-023 苏州和林微纳科技股份有限公司 关于使用自有资金支付募投项目所需资金并以募集 资金等额置换的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据证监会《上市公司募集资金监管规则》（2025 年 6 月 15 日起施行）《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》及公司 《募集资金管理制度》相关规定，苏州和林微纳科技股份有限公司(以下简称"公 司"）于 2025 年 6 月 13 日召开第二届董事会第十六次会议、第二届监事会第十 四次会议，分别审议通过了《关于使用自有资金支付募投项目所需资金并以募集 资金等额置换的议案》，同意公司及全资子公司作为实施主体在募投项目实施期 间，根据实际情况先行使用自有资金支付募投项目所需资金，在履行内部相关审 批程序后定期以募集资金等额置换。具体情况如下： 一、 募集资金基本情况 根据中国证券监督管理委员会《关于同意苏州和林微纳科技股份有限公司向 特定对象发行股票注册的批复》（证监许可[2022 ...

证券代码：688661 证券简称：和林微纳 编号：2025-024 苏州和林微纳科技股份有限公司 第二届监事会第十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 特此公告。 苏州和林微纳科技股份有限公司监事会 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 苏州和林微纳科技股份有限公司（以下简称"和林微纳"或"公司"）第二 届监事会第十四次会议（以下简称"本次会议"） 通知于 2025 年 6 月 3 日通过 传真、专人送达、邮件等方式送达全体监事，会议于 2025 年 6 月 13 日在苏州高 新区普陀山路 196 号公司会议室以现场及通讯相结合的方式召开。本次会议应出 席监事 3 人，现场及通讯方式出席监事 3 人，会议由监事长李德志先生主持，公 司其他相关人员列席。会议的召集和召开程序符合有关法律、行政法规、部门规 章、规范性文件和公司章程的规定，会议决议合法、有效。 二、监事会会议审议情况 （一）审议通过《关于使用自有资金支付募投项目所需资金并以募集资金 等额置换的议案》 经审议，监事会认为：公司使用自有资金支付募投项目 ...

Group 1 - Weijie Chuangxin plans to reduce its shareholding by up to 3%, amounting to no more than 12.91 million shares, due to personal funding needs [1] - Lier Chemical's major shareholder intends to reduce its stake by up to 3%, equivalent to no more than 24.01 million shares, for investment returns [1] - Helin Micro-Nano's controlling shareholder plans to reduce its shareholding by up to 1.5%, which is no more than 1.75 million shares, due to personal funding needs [2] Group 2 - Yifan Pharmaceutical received drug registration certificates for two products, indicating a focus on oncology and leukemia treatments [3] - *ST Jinbi is planning a change in control, leading to a temporary suspension of its stock trading [4] - Kexing Pharmaceutical's shareholder plans to reduce its stake by up to 3%, amounting to no more than 5.90 million shares, to optimize the equity structure [7] Group 3 - Li New Energy plans to invest approximately 1.25 billion yuan in three independent energy storage projects [7] - Kingsoft Office intends to acquire the remaining 31.98% stake in its subsidiary for 254 million yuan, aiming for full ownership [8] - Northeast Pharmaceutical received a CEP certificate from the European Medicines Agency for an antibiotic raw material, enhancing its product credibility [9] Group 4 - Tai'er Co. announced the lifting of a detention order on its controlling shareholder, changing it to a notice of supervision [10] - Runjian Co. won a bid for a solar power project worth approximately 83.92 million yuan, highlighting its role in the energy sector [11] - Jiuan Medical plans to register and issue medium-term notes and short-term financing bonds, with a total scale of up to 35 billion yuan and 5 billion yuan respectively [12] Group 5 - Wanma Co.'s chairman resigned due to work adjustments, but will remain as a board member [13] - Changhua Chemical plans to transfer 1% of its shares through an inquiry transfer method due to personal funding needs [14] - Jinkai Biotechnology's two shareholders plan to reduce their combined stake by up to 4%, totaling 481.6 thousand shares [15] Group 6 - Aeston plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy [16] - Maiwei Biotechnology's chairman proposed a share buyback plan with a total amount between 25 million and 50 million yuan [17] - Montai High-tech's specific shareholders and executives plan to reduce their stake by up to 3.03%, citing personal funding needs [18] Group 7 - *ST Dongjing's stock will resume trading after a change in control, with a new actual controller [20] - Tongdahai's major shareholders plan to reduce their combined stake by up to 3.57%, totaling 345.24 thousand shares [23]

中国经济网北京6月5日讯 和林微纳(688661.SH)昨日晚间披露《控股股东及实际控制人减持股份计划公 告》。 和林微纳首次公开发行股票的发行费用为4224.25万元，其中，保荐承销费用3164.53万元。 2022年，和林微纳向特定对象发行A股股票募集资金。根据中国证券监督管理委员会《关于同意苏州和 林微纳科技股份有限公司向特定对象发行股票注册的批复》（证监许可[2022]1105号）文件核准，和林 微纳向特定投资者发行人民币普通股股票9,874,453股，发行价为每股70.89元，募集资金总额人民币 699,999,973.17元，扣除发行费用（不含税）10,481,485.32元后，实际募集资金净额为人民币 689,518,487.85元。上述募集资金已经天衡会计师事务所（特殊普通合伙）出具的天衡验字（2022） 00122《验资报告》验证。 经计算，和林微纳两次募集资金合计10.54亿元。 2024年，和林微纳实现营业收入56,901.09万元，同比增长99.13%；实现归属于上市公司股东的净利 润-870.81万元，上年为-2,093.91万元；实现归属于上市公司股东的扣除非经常性损益的净利润-1 ...

证券代码：688661 证券简称：和林微纳 公告编号：2025-022 苏州和林微纳科技股份有限公司 控股股东及实际控制人减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东及董监高持有的基本情况 截止本报告披露日，苏州和林微纳科技股份有限公司（以下简称"公司"或 "和林微纳"）控股股东及实际控制人骆兴顺先生持有公司股份数量为 40,107,149 股，占公司总股本的 34.33%。以上股份为公司首次公开发行前取得 的股份（含上市以来资本公积转增股本取得的股份）、集中竞价交易增持取得及 非公开发行取得的股份，其中非公开发行部分为限售股，其余均为无限售流通股。 减持计划的主要内容 因自身资金需求，控股股东及实际控制人骆兴顺先生计划根据市场情况通过 集中竞价或大宗交易的方式减持其所持有的 IPO 前公司股份不超过 1,752,552 股，拟减持股份数量占公司当前总股本的比例不超过 1.50%。 上述股东减持期间为本公告披露 15 个交易日后的 3 个月内。减持价格将根 据减持时的 ...

和林微纳公告，控股股东及实际控制人骆兴顺因自身资金需求，计划减持不超过175.26万股，占公司总 股本的1.50%。减持方式为集中竞价或大宗交易，减持期间为2025年6月27日至9月26日。减持价格将根 据市场价格确定。 ...

Core Viewpoint - The semiconductor industry is experiencing a positive trend driven by cyclical recovery and domestic substitution, with expectations for the industry index to rebound [3][4]. Group 1: Market Performance - As of June 4, 2025, the CSI Semiconductor Industry Index (931865) increased by 0.21%, with notable gains from stocks such as Andl Micro-Nano (688661) up 8.27% and Deep Science and Technology (688328) up 4.16% [3]. - The Semiconductor Industry ETF (159582) has seen a 34.24% increase over the past year, with a recent price of 1.38 yuan [3][4]. - The ETF's trading volume showed a turnover rate of 3.37%, with a total transaction value of 6.4378 million yuan [3]. Group 2: Fund Performance - The Semiconductor Industry ETF has grown by 27.1742 million yuan in size over the past three months, ranking in the top half among comparable funds [4]. - Over the past six months, the ETF's shares increased by 31.5 million, also placing it in the top half of comparable funds [4]. - The ETF's net value rose by 34.46% in the past year, ranking 214 out of 2831 index equity funds, placing it in the top 7.56% [4]. Group 3: Investment Metrics - The ETF's Sharpe ratio for the past year is 1.11, indicating a favorable risk-adjusted return [5]. - The ETF's management fee is 0.50% and the custody fee is 0.10%, which are among the lowest in comparable funds [5]. - The tracking error for the ETF over the past year is 0.055%, the highest tracking precision among comparable funds [5]. Group 4: Top Holdings - The top ten weighted stocks in the CSI Semiconductor Industry Index account for 75.47% of the index, with North Huachuang (002371) holding the highest weight at 15.51% [5][7].

Core Viewpoint - The company has announced a profit distribution and capital increase plan, which includes a cash dividend of 0.08 yuan per share and a capital increase of 0.3 shares for every share held, approved at the annual general meeting on May 20, 2025 [2][3][4]. Distribution and Capital Increase Plan - The distribution is based on a total share capital of 116,836,789 shares, resulting in a total cash dividend payout of 9,346,943.12 yuan and a capital increase of 35,051,037 shares, leading to a new total share capital of 151,887,826 shares [4][10]. - The distribution will be executed for all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the record date [3][4]. Taxation and Dividend Distribution - For individual shareholders holding unrestricted shares, the actual cash dividend after tax will be 0.08 yuan per share, with a tax rate of 20% for shares held for one month or less, 10% for shares held between one month and one year, and no tax for shares held over one year [7][8]. - For shareholders holding restricted shares, the cash dividend after a 10% withholding tax will be 0.072 yuan per share [8][9]. - The company will not withhold taxes for other institutional investors, who will receive the pre-tax cash dividend of 0.08 yuan per share [9]. Share Structure Changes - The company confirms that all strategic placement shares from the initial public offering have been fully listed and are in circulation [5][10]. - The earnings per share for the fiscal year 2024, after the capital increase, is projected to be -0.0573 yuan based on the new total share capital [10].

| 股权登记日 | 除权（息）日 | 新增无限售条件流 | 现金红利发放日 | | --- | --- | --- | --- | | | | 通股份上市日 | | | 2025/6/5 | 2025/6/6 | 2025/6/6 | 2025/6/6 | 一、 通过分配、转增股本方案的股东大会届次和日期 本次利润分配及转增股本方案经公司2025 年 5 月 20 日的2024年年度股东大 会审议通过。 二、 分配、转增股本方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 证券代码：688661 证券简称：和林微纳 公告编号：2025-021 苏州和林微纳科技股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司存在首发战略配售股份，首发战略配售股份已全部上市流通 是否涉及差异化分红送转：否 每股分配比例，每股转增比例 每股现金红利0.08元 每股转增0.3股 相关日期 1. 发放年度：2024年年度 2. 分派对象： 公司上海分公司（以下简 ...